Pfizer Says 3 COVID-19 Shots Effective for Young Children, Will Push FDA to Authorize

Pfizer Says 3 COVID-19 Shots Effective for Young Children, Will Push FDA to Authorize
A nurse prepares a Pfizer vaccine overseen by a doctor in Sydney, Australia, on Oct. 3, 2021. Lisa Maree Williams/Getty Images
Jack Phillips
Updated:
0:00

Pfizer says that three shots of its mRNA COVID-19 vaccine offer protection for children aged 5 and younger, according to a May 23 announcement, as the pharmaceutical giant indicated that it would hand its data to federal health officials in its push to vaccinate small children.

Despite Pfizer’s proclamation, polls have suggested that parents of children aged 5 and younger are hesitant to give their children COVID-19 vaccines. In early May, a poll found that only 18 percent of such parents were eager to get their children vaccinated right away, while 38 percent said they were planning to wait—in spite of news reports claiming that some parents are anxiously waiting to vaccinate babies, toddlers, and preschoolers.
Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics